The global market for Transcatheter Aortic Valve Replacement (TAVR) was estimated to be worth US$ 4008.6 million in 2023 and is forecast to a readjusted size of US$ 12060 million by 2030 with a CAGR of 16.8% during the forecast period 2024-2030.

Transcatheter Aortic Valve Replacement (TAVR) Market

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.

East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.

In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Replacement (TAVR).

The Transcatheter Aortic Valve Replacement (TAVR) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcatheter Aortic Valve Replacement (TAVR) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transcatheter Aortic Valve Replacement (TAVR) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Transcatheter Aortic Valve Replacement (TAVR) Market Report

Report Metric	Details
Report Name	Transcatheter Aortic Valve Replacement (TAVR) Market
Forecasted market size in 2030	US$ 12060 million
CAGR	16.8%
Forecasted years	2024 - 2030
Segment by Type	Transfemoral Approach Transapical Approach Others
Segment by Application	Aortic Stenosis Aortic Regurgitation Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in global and regional level.
Chapter 3: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcatheter Aortic Valve Replacement (TAVR) revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Transcatheter Aortic Valve Replacement (TAVR) Market size in 2030?

Ans: The Transcatheter Aortic Valve Replacement (TAVR) Market size in 2030 will be US$ 12060 million.

What is the Transcatheter Aortic Valve Replacement (TAVR) Market share by type?

Ans: In terms of product, Transfemoral Approach is the largest segment, with a share over 80%.

Who are the main players in the Transcatheter Aortic Valve Replacement (TAVR) Market report?

Ans: The main players in the Transcatheter Aortic Valve Replacement (TAVR) Market are Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical

What are the Application segmentation covered in the Transcatheter Aortic Valve Replacement (TAVR) Market report?

Ans: The Applications covered in the Transcatheter Aortic Valve Replacement (TAVR) Market report are Aortic Stenosis, Aortic Regurgitation, Others

What are the Type segmentation covered in the Transcatheter Aortic Valve Replacement (TAVR) Market report?

Ans: The Types covered in the Transcatheter Aortic Valve Replacement (TAVR) Market report are Transfemoral Approach, Transapical Approach, Others

1 Study Coverage

1.1 Transcatheter Aortic Valve Replacement (TAVR) Product Introduction

1.2 Market by Type

1.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Transfemoral Approach

1.2.3 Transapical Approach

1.2.4 Others

1.3 Market by Application

1.3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Aortic Stenosis

1.3.3 Aortic Regurgitation

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Estimates and Forecasts

2.2 Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2023 Versus 2030

2.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region: 2019-2024

2.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Region (2025-2030)

2.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2019-2030)

3 Global Transcatheter Aortic Valve Replacement (TAVR) by Company

3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2019-2024)

3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Company (2019-2024)

3.3 Competitive Landscape

3.3.1 Key Transcatheter Aortic Valve Replacement (TAVR) Companies around the World: Ranking by Revenue

3.3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.3.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Transcatheter Aortic Valve Replacement (TAVR) Companies Headquarters & Product Type

3.4.1 Transcatheter Aortic Valve Replacement (TAVR) Companies Headquarters

3.4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Companies Product & Service

3.4.3 Date of International Companies Enter into Transcatheter Aortic Valve Replacement (TAVR) Market

3.5 Global Transcatheter Aortic Valve Replacement (TAVR) Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Edwards Lifesciences

4.1.1 Edwards Lifesciences Company Information

4.1.2 Edwards Lifesciences Description, Business Overview

4.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.1.5 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.1.6 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.1.7 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.1.8 Edwards Lifesciences Recent Developments

4.2 Medtronic

4.2.1 Medtronic Company Information

4.2.2 Medtronic Description, Business Overview

4.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.2.5 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.2.6 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.2.7 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.2.8 Medtronic Recent Developments

4.3 Abbott

4.3.1 Abbott Company Information

4.3.2 Abbott Description, Business Overview

4.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.3.5 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.3.6 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.3.7 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.3.8 Abbott Recent Developments

4.4 Boston Scientific

4.4.1 Boston Scientific Company Information

4.4.2 Boston Scientific Description, Business Overview

4.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.4.5 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.4.6 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.4.7 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.4.8 Boston Scientific Recent Developments

4.5 Meril Life Sciences

4.5.1 Meril Life Sciences Company Information

4.5.2 Meril Life Sciences Description, Business Overview

4.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.5.5 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.5.6 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.5.7 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.5.8 Meril Life Sciences Recent Developments

4.6 Venus Medtech

4.6.1 Venus Medtech Company Information

4.6.2 Venus Medtech Description, Business Overview

4.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.6.5 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.6.6 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.6.7 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.6.8 Venus Medtech Recent Development

4.7 Bracco (HLT)

4.7.1 Bracco (HLT) Company Information

4.7.2 Bracco (HLT) Description, Business Overview

4.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.7.5 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.7.6 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.7.7 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.7.8 Bracco (HLT) Recent Development

4.8 JenaValve Technology

4.8.1 JenaValve Technology Company Information

4.8.2 JenaValve Technology Description, Business Overview

4.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.8.5 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.8.6 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.8.7 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.8.8 JenaValve Technology Recent Development

4.9 Suzhou Jiecheng Medical Technology Co.

4.9.1 Suzhou Jiecheng Medical Technology Co. Company Information

4.9.2 Suzhou Jiecheng Medical Technology Co. Description, Business Overview

4.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.9.5 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.9.6 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.9.7 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.9.8 Suzhou Jiecheng Medical Technology Co. Recent Development

4.10 Peijia Medical

4.10.1 Peijia Medical Company Information

4.10.2 Peijia Medical Description, Business Overview

4.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products Offered

4.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)

4.10.5 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2023

4.10.6 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2023

4.10.7 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2023

4.10.8 Peijia Medical Recent Development

5 Breakdown Data by Type

5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)

5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Type (2025-2030)

5.3 Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)

6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Application (2025-2030)

6.3 Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2030)

7 North America

7.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2019-2030

7.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2019-2030)

7.3 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)

7.4 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Region (2019-2030)

8.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)

8.4 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)

9 Europe

9.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2019-2030

9.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2019-2030)

9.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)

9.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)

10 Latin America

10.1 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2019-2030

10.2 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2019-2030)

10.3 Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)

10.4 Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2019-2030)

11.3 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)

11.4 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Transcatheter Aortic Valve Replacement (TAVR) Supply Chain Analysis

12.2 Transcatheter Aortic Valve Replacement (TAVR) Key Raw Materials and Upstream Suppliers

12.3 Transcatheter Aortic Valve Replacement (TAVR) Clients Analysis

12.4 Transcatheter Aortic Valve Replacement (TAVR) Sales Channel and Sales Model Analysis

12.4.1 Transcatheter Aortic Valve Replacement (TAVR) Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Transcatheter Aortic Valve Replacement (TAVR) Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Transcatheter Aortic Valve Replacement (TAVR) Distributors

13 Market Dynamics

13.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends

13.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers

13.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges

13.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Suzhou Jiecheng Medical Technology Co.

Peijia Medical

List of Tables

Table 1. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Companies of Transfemoral Approach

Table 3. Major Companies of Transapical Approach

Table 4. Major Companies of Others

Table 5. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (US$ Million): 2023 VS 2030

Table 7. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 9. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2019-2024) & (US$ Million)

Table 10. Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Company (2019-2024)

Table 11. Ranking of Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue (US$ Million) in 2023

Table 12. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 13. Global Transcatheter Aortic Valve Replacement (TAVR) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2023)

Table 14. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Headquarters

Table 15. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Product & Service

Table 16. Date of International Companies Enter into Transcatheter Aortic Valve Replacement (TAVR) Market

Table 17. Global Transcatheter Aortic Valve Replacement (TAVR) Mergers & Acquisitions, Expansion Plans

Table 18. Edwards Lifesciences Company Information

Table 19. Edwards Lifesciences Description and Business Overview

Table 20. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product

Table 21. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 22. Edwards Lifesciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 23. Edwards Lifesciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 24. Edwards Lifesciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 25. Edwards Lifesciences Recent Development

Table 26. Medtronic Company Information

Table 27. Medtronic Description and Business Overview

Table 28. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product

Table 29. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 30. Medtronic Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 31. Medtronic Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 32. Medtronic Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 33. Medtronic Recent Development

Table 34. Abbott Company Information

Table 35. Abbott Description and Business Overview

Table 36. Abbott Transcatheter Aortic Valve Replacement (TAVR) Product

Table 37. Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 38. Abbott Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 39. Abbott Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 40. Abbott Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 41. Abbott Recent Development

Table 42. Boston Scientific Company Information

Table 43. Boston Scientific Description and Business Overview

Table 44. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product

Table 45. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 46. Boston Scientific Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 47. Boston Scientific Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 48. Boston Scientific Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 49. Boston Scientific Recent Development

Table 50. Meril Life Sciences Company Information

Table 51. Meril Life Sciences Description and Business Overview

Table 52. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product

Table 53. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 54. Meril Life Sciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 55. Meril Life Sciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 56. Meril Life Sciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 57. Meril Life Sciences Recent Development

Table 58. Venus Medtech Company Information

Table 59. Venus Medtech Description and Business Overview

Table 60. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product

Table 61. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 62. Venus Medtech Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 63. Venus Medtech Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 64. Venus Medtech Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 65. Venus Medtech Recent Development

Table 66. Bracco (HLT) Company Information

Table 67. Bracco (HLT) Description and Business Overview

Table 68. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product

Table 69. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 70. Bracco (HLT) Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 71. Bracco (HLT) Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 72. Bracco (HLT) Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 73. Bracco (HLT) Recent Development

Table 74. JenaValve Technology Company Information

Table 75. JenaValve Technology Description and Business Overview

Table 76. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product

Table 77. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 78. JenaValve Technology Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 79. JenaValve Technology Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 80. JenaValve Technology Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 81. JenaValve Technology Recent Development

Table 82. Suzhou Jiecheng Medical Technology Co. Company Information

Table 83. Suzhou Jiecheng Medical Technology Co. Description and Business Overview

Table 84. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product

Table 85. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 86. Suzhou Jiecheng Medical Technology Co. Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 87. Suzhou Jiecheng Medical Technology Co. Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 88. Suzhou Jiecheng Medical Technology Co. Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 89. Suzhou Jiecheng Medical Technology Co. Recent Development

Table 90. Peijia Medical Company Information

Table 91. Peijia Medical Description and Business Overview

Table 92. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product

Table 93. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 94. Peijia Medical Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2023

Table 95. Peijia Medical Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2023

Table 96. Peijia Medical Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2023

Table 97. Peijia Medical Recent Development

Table 98. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024) & (US$ Million)

Table 99. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 100. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024) & (US$ Million)

Table 101. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 102. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024) & (US$ Million)

Table 103. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030) & (US$ Million)

Table 104. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024) & (US$ Million)

Table 105. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024) & (US$ Million)

Table 106. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2019-2030) & (US$ Million)

Table 107. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2025-2030) & (US$ Million)

Table 108. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024) & (US$ Million)

Table 109. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024) & (US$ Million)

Table 110. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024) & (US$ Million)

Table 111. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030) & (US$ Million)

Table 112. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024) & (US$ Million)

Table 113. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024) & (US$ Million)

Table 114. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024) & (US$ Million)

Table 115. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030) & (US$ Million)

Table 116. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024) & (US$ Million)

Table 117. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024) & (US$ Million)

Table 118. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024) & (US$ Million)

Table 119. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030) & (US$ Million)

Table 120. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024) & (US$ Million)

Table 121. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024) & (US$ Million)

Table 122. Transcatheter Aortic Valve Replacement (TAVR) Key Raw Materials, Industry Status and Trend

Table 123. Transcatheter Aortic Valve Replacement (TAVR) Key Raw Materials and Upstream Suppliers

Table 124. Transcatheter Aortic Valve Replacement (TAVR) Clients Status and Trend

Table 125. Transcatheter Aortic Valve Replacement (TAVR) Typical Clients

Table 126. Transcatheter Aortic Valve Replacement (TAVR) Distributors

Table 127. Transcatheter Aortic Valve Replacement (TAVR) Market Trends

Table 128. Transcatheter Aortic Valve Replacement (TAVR) Market Drivers

Table 129. Transcatheter Aortic Valve Replacement (TAVR) Market Challenges

Table 130. Transcatheter Aortic Valve Replacement (TAVR) Market Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Transcatheter Aortic Valve Replacement (TAVR) Product Picture

Figure 2. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type in 2023 & 2030

Figure 3. Transfemoral Approach Product Picture

Figure 4. Transapical Approach Product Picture

Figure 5. Others Product Picture

Figure 6. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application in 2023 & 2030

Figure 7. Aortic Stenosis

Figure 8. Aortic Regurgitation

Figure 9. Others

Figure 10. Transcatheter Aortic Valve Replacement (TAVR) Report Years Considered

Figure 11. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size 2019-2030 (US$ Million)

Figure 13. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Market Share by Region: 2023 Versus 2030

Figure 14. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2019-2030)

Figure 15. Transcatheter Aortic Valve Replacement (TAVR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 16. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share Forecast by Type (2019-2030)

Figure 17. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share Forecast by Application (2019-2030)

Figure 18. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue 2019-2030 (US$ Million)

Figure 19. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2024)

Figure 20. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2024)

Figure 21. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue 2019-2030 (US$ Million)

Figure 22. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2019-2030)

Figure 23. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2024)

Figure 24. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2024)

Figure 25. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 26. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Country (2019-2030)

Figure 27. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2024)

Figure 28. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2024)

Figure 29. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 30. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Country (2019-2024)

Figure 31. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2024)

Figure 32. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2024)

Figure 33. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 34. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Country (2019-2030)

Figure 35. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2024)

Figure 36. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2024)

Figure 37. Transcatheter Aortic Valve Replacement (TAVR) Supply Chain (Upstream and Downstream Market)

Figure 38. Global Production Market Share of Transcatheter Aortic Valve Replacement (TAVR) Raw Materials by Region in 2023

Figure 39. Transcatheter Aortic Valve Replacement (TAVR) Distribution Channels

Figure 40. Global Transcatheter Aortic Valve Replacement (TAVR) Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 41. Global Transcatheter Aortic Valve Replacement (TAVR) Percentage 2019-2030: Online Sales VS Offline Sales

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

Figure 45. Global Transcatheter Aortic Valve Replacement (TAVR) Percentage 2019-2030: Online Sales VS Offline Sales

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Temporary Myocardial Pacing Lead Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25J15543

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Remote Cardiac Patient Monitoring Platform Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12Q15835

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cholesterol Vaccines Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13X16294

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Global Mitral Valve Clip System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33S15377

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions